scholarly journals Stabilization of Hypoxia-Inducible Factor-1 Alpha Augments the Therapeutic Capacity of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Pneumonia

2018 ◽  
Vol 5 ◽  
Author(s):  
Naveen Gupta ◽  
Victor Nizet
2009 ◽  
Vol 209 (3) ◽  
pp. S88
Author(s):  
Sae Hee Ko ◽  
Denise A. Chan ◽  
Jason P. Glotzbach ◽  
Amato J. Giaccia ◽  
Geoffrey C. Gurtner ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Chao Liu ◽  
Jing-Wen Zhang ◽  
Liang Hu ◽  
Yi-Chen Song ◽  
Lu Zhou ◽  
...  

A local renin-angiotensin system (RAS) is expressed in mesenchymal stem cells (MSCs) and regulates stem cell function. The local RAS influences the survival and tissue repairing ability of transplanted stem cells. We have previously reported that angiotensin II (Ang II) pretreatment can significantly increase vascular endothelial growth factor (VEGF) synthesis in MSCs through the ERK1/2 and Akt pathways via the Ang II receptor type 1 (AT1R). However, the role of angiotensin-converting enzyme (ACE) has not been clarified. Furthermore, whether Ang II pretreatment activates hypoxia-inducible factor-1α(HIF-1α) in MSCs has not been elucidated. Our data show that both ACE and HIF-1αare involved in promoting VEGF expression in MSCs, and that both are upregulated by Ang II stimulation. The upregulation of ACE appeared after the rapid degradation of exogenous Ang II, and led to the formation of endogenous Ang II. On the other hand, the ACE inhibitor, captopril, attenuated Ang II-enhanced HIF-1αupregulation, while HIF-1αsuppression markedly attenuated ACE expression. This interesting finding suggests an interaction between ACE and HIF-1α. We conclude that Ang II pretreatment, as a trigger, activated the AT1R/HIF-1α/ACE axis that then mediated Ang II-induced VEGF synthesis in MSCs.


2017 ◽  
Vol 8 (1) ◽  
Author(s):  
Victor G. Martinez ◽  
Imelda Ontoria-Oviedo ◽  
Carolina P. Ricardo ◽  
Sian E. Harding ◽  
Rosa Sacedon ◽  
...  

2013 ◽  
Vol 22 (3) ◽  
pp. 501-511 ◽  
Author(s):  
Inmaculada Cerrada ◽  
Amparo Ruiz-Saurí ◽  
Rubén Carrero ◽  
César Trigueros ◽  
Akaitz Dorronsoro ◽  
...  

2009 ◽  
Vol 2009 ◽  
pp. 1-10 ◽  
Author(s):  
Jinfu Yang ◽  
Tao Tang ◽  
Feng Li ◽  
Wenwu Zhou ◽  
Jian Liu ◽  
...  

Objective.To construct the eukaryotic expression vector hypoxia-inducible factor 1α-pcDNA3.1and to investigate its transfective efficiency into mesenchymal stem cells (MSCs) in vitro and the expression of HIF-1αgene in MSCs.Methods.mRNA of Wistar Rats' myocardial cells was extracted, and cDNA was synthesized with Reverse Transcription Kit, HIF-1αwas amplified by polymerase chain reaction (PCR), and constructed intopcDNA3.1. Transfected HIF-1α-pcDNA3.1into MSCs by liposome mediated method. The expression of HIF-1αin the cells was detected by Western Blot Analysis and ELISA.Results.Eukaryotic expression vector HIF-1α-pcDNA3.1was constructed successfully. Analyzed by flow cytometer, The MSCs' surfaces mark were CD44+, SH3(CD73)+, CD34−, CD45−and the CD44+ cells and SH3(CD73)+ cells were 94.7% and 97.3%, respectively, showing the high purity of the cultured MSCs. After inducing, the cultured MSCs can differentiate into osteoblasts and adipocytes successfully. In HIF-1αgene transfected MSCs, the expression of HIF-1αmRNA and HIF-1αprotein were both increased obviously.Conclusion.HIF-1αwas cloned successfully. HIF-1α-pcDNA3.1can be transfected into MSCs by liposome-mediated method effectively and which resulting stable expression of HIF-1αin transfected MSCs.


Sign in / Sign up

Export Citation Format

Share Document